The new business venture by the Trump family is generating intensifying criticism and ethics questions, even as it has turned into an overnight phenomenon, generating a windfall on paper. By Eric ...
Sino Biopharmaceutical CEO Eric Tse discusses the outlook of the company, Asian pharmaceutical markets, and the potential impacts from US President Donald Trump's tariffs and policy. Tse speaks to ...